Eom Pharmaceuticals

(OTC) IMUC

Current Price$0.09

Market Cap$9.65M

Since IPO (2021)-83%

5 Year-83%

1 Year-10%

1 Month-50%

Eom Pharmaceuticals Financials at a Glance

Market Cap

$9.65M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.09

Volume

Open

$0.08

Price

$0.09

Volume

Open

$0.08

Previous Close

$0.09

Daily Range

$0.08 - $0.14

52-Week Range

$0.04 - $0.34

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.09

Volume

Open

$0.08

Previous Close

$0.09

Daily Range

$0.08 - $0.14

52-Week Range

$0.04 - $0.34

IMUC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eom Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Irach B. Taraporewala, PhD

Website

www.eompharma.com

Headquarters

Montvale, NJ 07645, US

IMUC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.65M

Shares Outstanding

113.27M

Volume

Avg. Volume

2.93K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.83M

EBITDA

$1.83M

Operating Cash Flow

$1.49M

Capital Expenditure

$3.00

Free Cash Flow

$1.49M

Cash & ST Invst.

$29.76K

Total Debt

$1.76M

Eom Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.65M

N/A

Market Cap/Employee

$3.22M

N/A

Employees

N/A

Net Income

$464.52K

-15671.9%

EBITDA

$315.40K

N/A

Quarterly Fundamentals

Name

Q4 2022YOY CHG

Net Cash

$2.85M

-140.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$619.94K

-48.4%

Short Term Debt

$2.85M

N/A

Return on Assets

-19.33%

N/A

Return on Invested Capital

1.70%

N/A

Free Cash Flow

$687.93K

N/A

Operating Cash Flow

$687.93K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PRVCFPreveCeutical Medical Inc.

PRVCFPreveCeutical Medical Inc.$0.02+0.00%

NYMXFNymox Pharmaceutical Corporation

NYMXFNymox Pharmaceutical Corporation$0.07+9.83%

LVCLFAlgorae Pharmaceuticals Limited

LVCLFAlgorae Pharmaceuticals Limited$0.01+0.00%

HOOKHOOKIPA Pharma Inc.

HOOKHOOKIPA Pharma Inc.$1.19+1.28%

SRBCFSirona Biochem Corp.

SRBCFSirona Biochem Corp.$0.01+0.00%

PPCBPropanc Biopharma, Inc.

PPCBPropanc Biopharma, Inc.$0.10+1.67%

DVHGFDevonian Health Group Inc.

DVHGFDevonian Health Group Inc.$10.65+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

Questions About IMUC

What is the current price of Eom Pharmaceuticals?

Eom Pharmaceuticals is trading at $0.09 per share.

What is the 52-week range for Eom Pharmaceuticals?

Over the past 52 weeks, Eom Pharmaceuticals has traded between $0.04 and $0.34.

How much debt does Eom Pharmaceuticals have?

As of the most recent reporting period, Eom Pharmaceuticals reported total debt of $1.76M.

How much cash does Eom Pharmaceuticals have on hand?

Eom Pharmaceuticals reported $29,758 in cash and cash equivalents in its most recent financial results.

What is Eom Pharmaceuticals’s dividend yield?

Eom Pharmaceuticals does not currently have a dividend yield.

Eom Pharmaceuticals

Eom Pharmaceuticals Financials at a Glance

IMUC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Eom Pharmaceuticals

IMUC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Eom Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMUC

What is the current price of Eom Pharmaceuticals?

What is the 52-week range for Eom Pharmaceuticals?

How much debt does Eom Pharmaceuticals have?

How much cash does Eom Pharmaceuticals have on hand?

What is Eom Pharmaceuticals’s dividend yield?

Premium Investing Services